Fevertree Drinks plc isn’t the only stunning growth stock on the market

G A Chester discusses the investment outlook for AIM star Fevertree Drinks plc (LON:FEVR) and a flying FTSE 250 growth stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of Electrocomponents (LSE: ECM) have moved higher on a positive trading update today. The global distributor for engineers reported underlying revenue growth of 14% for the four months to 31 January and said it’s confident of delivering “strong progress” for its full financial year, which ends on 31 March.

At a current share price of 622p (up 1.7% on the day), this FTSE 250 firm has a market capitalisation of £2.75bn. I reckon now could be a good time to buy a slice of the business.

Improving performer

In today’s update, Electrocomponents said it saw top-line growth across all five of its regions. On the profit front, it advised it remains on track to deliver a stable gross margin for the year. The consensus of City analysts is for this to feed down to a pre-tax profit of £164m and earnings per share (EPS) of 26.6p — 27% ahead of last year. This gives a price-to-earnings (P/E) ratio of 23.4, which looks reasonable value to me in the context of the EPS growth.

At the end of the current financial year the company will have completed the first phase of its Performance Improvement Plan and delivered cumulative annualised savings of £30m. Furthermore, management said today: “We still believe we have a significant further opportunity to improve efficiency and reduce complexity, allowing continued strong growth at higher operating margins.”

The momentum in the business, the group’s wide geographical diversification and a continuing positive market backdrop all lead me to a favourable view of the outlook for Electrocomponents.

Jaw-dropping achievement

The rise of premium mixers company Fevertree Drinks (LSE: FEVR) has been truly phenomenal. An idea of the scale of its success can be gleaned from a comparison with soft drinks group AG Barr, whose brands include Irn-Bru, Rubicon and Strathmore.

Barr made a profit of £33m over the last 12 months. Fevertree topped it with £37.5m. The companies having been founded in 1875 and 2004, respectively, the jaw-dropping fact is it’s taken Fevertree just 13 years to exceed what it’s taken Barr 142 years to achieve.

Difficult call

At a current share price of 2,400p, AIM-listed Fevertree has a market capitalisation of £2.77bn, which compares with FTSE 250-listed Barr’s £0.76bn. Fevertree trades on a P/E of 62.8 based on forecasts of 38.2p EPS for its latest financial year. The Irn-Bru maker’s P/E is 21.8.

The question of whether Fevertree’s sky-high P/E is justified by its phenomenal growth is one that writers at the Motley Fool have divergent views on. For example, Roland Head has argued that Fevertree could still be a buying opportunity, while Peter Stephens has it down as a stock to avoid like the plague.

I think it’s a difficult call. Analysts expect EPS growth to slow to 10% for 2018 and 15% for 2019, as the company accelerates investment in international expansion, with the North American market appearing to be a particularly prominent ambition.

However, any hiccup or setback in executing its strategy could see the shares severely punished, because they’re trading on such a high rating. The same could be true in the event of a broad market correction, which is looking increasingly overdue. Add into the mix the fact that Schweppes has decided to fight back aggressively in Fevertree’s home territory and I lean towards rating the stock a ‘sell’.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended AG Barr. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

2 of the widest moats in the FTSE 100

A durable competitive advantage is key to a good investment. And Stephen Wright thinks a couple of FTSE 100 firms…

Read more »

Investing Articles

A 9.6% yield but down 14%! Should I consider this FTSE gem for my dividend portfolio?

There are several things to consider when looking for FTSE shares with dividend potential. Here, our writer outlines his evaluation…

Read more »

Young Asian man shopping in a supermarket
Investing Articles

I’d shun Lloyds Banking Group and consider this stock for passive income instead

This company's dividend record knocks spots off Lloyds Banking Group's, and it looks like decent value now with a yield…

Read more »

Investing Articles

Will the 5.6% BT Group dividend yield grow in 2024?

Zaven Boyrazian explores whether BT Group can continue hiking its dividend and if the telecoms giant belongs in his income…

Read more »

Investing Articles

FTSE 100’s near a 52-week high, but this stock’s still dirt cheap!

The FTSE 100's on the rise, but not all stocks have been so fortunate. Here’s one company that got left…

Read more »

Investing Articles

Is this ‘secret weapon’ a multi-billion pound reason to buy Lloyds shares?

Dr James Fox explains how Lloyds shares could rise even higher as the bank's 'strategic hedge' is likely to boost…

Read more »

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

3 of the best penny stocks for growth, dividends, and value!

Looking for top penny stocks to buy? Royston Wild believes these UK small-cap shares could prove lucrative investments in the…

Read more »

Investing Articles

How I’d aim to turn an empty ISA into £275k by purchasing cheap shares this summer

Harvey Jones is taking advantage of the summer stock market lull to buy cheap shares and build a high and…

Read more »